Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-13-041753
Filing Date
2013-07-29
Accepted
2013-07-29 18:40:34
Documents
2
Period of Report
2013-07-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v351176_3a.html 3/A  
1 OWNERSHIP DOCUMENT v351176_3a.xml 3/A 3003
2 EXHIBIT 24 v351176_ex24.htm EX-24 7923
  Complete submission text file 0001144204-13-041753.txt   12349
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
RAYNOR DANIEL (Reporting) CIK: 0001068854 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-31812 | Film No.: 13993711